Pharmacologic and Surgical Retreatment After Office-based Treatments for Benign Prostatic Hyperplasia: A Systematic Review

Michael Baboudjian (1) , Jean-Nicolas Cornu (2, 3, 4, 5) , Bastien Gondran-Tellier (1) , Marc Fourmarier (6) , Grégoire Robert (7) , Benoit Peyronnet (8) , Vincent Misrai (9) , Benjamin Pradere (10, 11)

1 LA CONCEPTION - Hôpital de la Conception [CHU - APHM]
2 ADEN - Nutrition, Inflammation et axe Microbiote-Intestin-Cerveau
3 IRIB - Institute for Research and Innovation in Biomedicine
4 UNIROUEN - Université de Rouen Normandie
5 Service d'urologie [Rouen]
6 Urologie CH Aix-Pertuis
7 service d'urologie [CHU Bordeaux]
8 Service d'urologie [Rennes] = Urology [Rennes]
9 Clinique Pasteur [Toulouse]
10 Service de Médecine de la Reproduction, Clinique Croix du Sud, Quint-Fonsegrives, France.
11 Medizinische Universität Wien = Medical University of Vienna

Domaines: Sciences de l'Homme et Société

Michael Baboudjian, Jean-Nicolas Cornu, Bastien Gondran-Tellier, Marc Fourmarier, Grégoire Robert, et al.. Pharmacologic and Surgical Retreatment After Office-based Treatments for Benign Prostatic Hyperplasia: A Systematic Review. European Urology Focus, 2023, ⟨10.1016/j.euf.2023.03.004⟩. ⟨hal-04048598⟩